ANAPTYSBIO, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2016 | $-2.1M | $-2.1M | $35.0K | — |
| Jun 2016 | $1.7M | $1.7M | $14.0K | — |
| Sep 2016 | $-3.1M | $-3.1M | $0 | — |
| Mar 2017 | $-8.1M | $-8.2M | $85.0K | — |
| Jun 2017 | $-2.6M | $-2.7M | $68.0K | — |
| Sep 2017 | $-3.9M | $-3.9M | $13.0K | — |
| Mar 2018 | $-12.5M | $-12.7M | $232.0K | — |
| Jun 2018 | $-8.9M | $-9.2M | $304.0K | — |
| Sep 2018 | $-14.9M | $-15.2M | $321.0K | — |
| Mar 2019 | $-16.1M | $-16.3M | $180.0K | — |
| Jun 2019 | $-15.5M | $-15.8M | $241.0K | — |
| Sep 2019 | $-22.1M | $-22.4M | $280.0K | — |
| Mar 2020 | $-15.1M | $-15.2M | $87.0K | — |
| Jun 2020 | $-19.6M | $-19.7M | $83.0K | — |
| Sep 2020 | $-17.0M | $-17.1M | $88.0K | — |
| Mar 2021 | $-23.2M | $-23.5M | $317.0K | $3.3M |
| Jun 2021 | $9.6M | $8.7M | $863.0K | — |
| Sep 2021 | $-7.0M | $-7.2M | $172.0K | — |
| Mar 2022 | $-21.0M | $-21.1M | $55.0K | $7.7M |
| Jun 2022 | $-24.1M | $-24.2M | $78.0K | — |
| Sep 2022 | $-17.7M | $-17.8M | $50.0K | — |
| Mar 2023 | $-24.6M | $-24.7M | $175.0K | $8.9M |
| Jun 2023 | $-25.4M | $-25.6M | $190.0K | — |
| Sep 2023 | $-36.5M | $-36.6M | $162.0K | — |
| Mar 2024 | $-37.3M | $-37.3M | $27.0K | $10.1M |
| Jun 2024 | $-21.3M | $-21.4M | $33.0K | — |
| Sep 2024 | $-10.1M | $-10.1M | $35.0K | — |
| Mar 2025 | $-10.7M | $-10.7M | $35.0K | $9.2M |
| Jun 2025 | $-40.2M | $-40.3M | $39.0K | — |
| Sep 2025 | $-27.4M | $-27.4M | $12.0K | — |
| Mar 2026 | $-25.9M | $-25.9M | $17.0K | $14.2M |